Read + Share
Amedeo Smart
Independent Medical Education
Bueno C, Barrera S, Bataller A, Ortiz-Maldonado V, et al. CD34+CD19-CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies. Blood 2022;140:38-44.PMID: 35421218
Email
LinkedIn
Facebook
Twitter
Privacy Policy